Evidence map›Paper›PMID 27150362›Full record

ArticlemBio2016

Whole-Genome Sequencing for Routine Pathogen Surveillance in Public Health: a Population Snapshot of Invasive Staphylococcus aureus in Europe.

David M Aanensen, Edward J Feil, Matthew T G Holden, Janina Dordel, Corin A Yeats, Artemij Fedosejev, Richard Goater, Santiago Castillo-Ramírez, Jukka Corander, Caroline Colijn and 14 more

Abstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Methicillin-ResistantInternational journal of molecular sciences · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Prevalence and Diversity ofAnimals : an open access journal from MDPI · 2025
    Article
  11. Article
  12. Review
  13. Methicillin-sensitiveMicrobial genomics · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. SaLTy: a novelMicrobial genomics · 2024
    Article
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

David M AanensenDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom The Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Edward J FeilThe Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom.
Matthew T G HoldenSchool of Medicine, University of St. Andrews, St. Andrews, United Kingdom Pathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.
Janina DordelPathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom Department of Biology, Drexel University, Philadelphia, Pennsylvania, USA.
Corin A YeatsDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom The Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Artemij FedosejevDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom The Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Richard GoaterThe Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Santiago Castillo-RamírezPrograma de Genómica Evolutiva, Centro de Ciencias Genómicas, Universidad Nacional Autónoma de Mexico, Cuernavaca, Morelos, Mexico.
Jukka CoranderHelsinki Institute for Information Technology HIIT, Aalto, Finland.
Caroline ColijnDepartment of Mathematics, Imperial College London, London, United Kingdom.
Monika A ChlebowiczDepartment of Medical Microbiology, University Medical Center Groningen, Rijksuniversteit Groningen, Groningen, The Netherlands.
Leo SchoulsNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Max HeckNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Gerlinde PluisterNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Raymond RuimyCentre Hospitalier Universitaire de Nice, Nice, France.
Gunnar KahlmeterEUCAST Development Laboratory, Växjö, Sweden.
Jenny ÅhmanEUCAST Development Laboratory, Växjö, Sweden.
Erika MatuschekEUCAST Development Laboratory, Växjö, Sweden.
Alexander W FriedrichDepartment of Medical Microbiology, University Medical Center Groningen, Rijksuniversteit Groningen, Groningen, The Netherlands.
Julian ParkhillPathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.ORCID 0000-0002-7069-5958
Stephen D BentleyPathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.
Brian G SprattDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Hajo GrundmannDepartment of Medical Microbiology, University Medical Center Groningen, Rijksuniversteit Groningen, Groningen, The Netherlands Department of Infection Prevention and Hospital Hygiene, Faculty of Medicine, University of Freiburg, Freiburg, Germany hajo.grundmann@uniklinik-freiburg.de.
European SRL Working Group

Funding

Medical Research Council G1000803Wellcome Trust 089472Wellcome Trust 098051Wellcome Trust 099202
6 · The paper itself

Abstract

unlabelledThe implementation of routine whole-genome sequencing (WGS) promises to transform our ability to monitor the emergence and spread of bacterial pathogens. Here we combined WGS data from 308 invasive Staphylococcus aureus isolates corresponding to a pan-European population snapshot, with epidemiological and resistance data. Geospatial visualization of the data is made possible by a generic software tool designed for public health purposes that is available at the project URL (http://www.microreact.org/project/EkUvg9uY?tt=rc). Our analysis demonstrates that high-risk clones can be identified on the basis of population level properties such as clonal relatedness, abundance, and spatial structuring and by inferring virulence and resistance properties on the basis of gene content. We also show that in silico predictions of antibiotic resistance profiles are at least as reliable as phenotypic testing. We argue that this work provides a comprehensive road map illustrating the three vital components for future molecular epidemiological surveillance: (i) large-scale structured surveys, (ii) WGS, and (iii) community-oriented database infrastructure and analysis tools. IMPORTANCE: The spread of antibiotic-resistant bacteria is a public health emergency of global concern, threatening medical intervention at every level of health care delivery. Several recent studies have demonstrated the promise of routine whole-genome sequencing (WGS) of bacterial pathogens for epidemiological surveillance, outbreak detection, and infection control. However, as this technology becomes more widely adopted, the key challenges of generating representative national and international data sets and the development of bioinformatic tools to manage and interpret the data become increasingly pertinent. This study provides a road map for the integration of WGS data into routine pathogen surveillance. We emphasize the importance of large-scale routine surveys to provide the population context for more targeted or localized investigation and the development of open-access bioinformatic tools to provide the means to combine and compare independently generated data with publicly available data sets.

Indexed as

Epidemiological MonitoringGenome, BacterialComputational BiologyComputer SimulationDisease OutbreaksDrug Resistance, BacterialEuropeHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNASoftwareStaphylococcal InfectionsStaphylococcus aureus

Identifiers

PMID27150362
PMCPMC4959656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.